- What types of requests will be considered?
Independent Medical Education (IME) and Patient Education Grant Requests:
Teva is committed to supporting innovative, high-quality initiatives that provide the healthcare professional with evidence-based, clinically-relevant, performance-based education and patient education by which health professionals and others communicate information to patients and their caregivers that will alter their health behaviors or improve their health status. Please refer to the Education Platform for Therapeutic Area Education Objectives and to the other resources on www.TevaRequests.com to help with your submission. For consideration, all requests must have the required documentation; please note that multi-supported programs are preferable. Should you require assistance please contact the Medical Education team at: TevaRequestManagement@tevapharm.com or leave a message on 1-800-961-3604 for a return call within 3 business days.
Teva will not support requests to purchase equipment, provide salary support of the employees of health care providers, or to provide general operational support.
- Who is considered a qualified organization?
For U.S. Medical Educational and Patient Education requests, qualified organizations are those that provide educational opportunities for physicians, other health care professionals, patients and caregivers. The organizations are responsible for the content, quality, scientific integrity, and Open Payments reporting (if any) of all activities.
- What therapeutic areas and disease states does Teva support?
For current information and updates on the disease states and therapeutic areas of interest to Teva, please review our Educational Platform here
- When should I submit a request?
Please submit your request at least 60 days prior to the date that you require a decision. The RMS Portal must receive your completed request (including all necessary supporting documentation) no less than 60 days from the start date of your planned activity. Please note that if the date of your event is less than 60 days in advance of receipt of your completed request, your grant request may not be accepted for consideration.
- May I submit a request for an activity that has already occurred?
No, Teva U.S. Medical Education and Patient Education do not fund activities that have already occurred. Teva requires that you submit your request at least 60 calendar days prior to the date that you require a decision.
- How long will it take Teva to review my request?
Review times vary from request to request; however, the general guidance is up to 60 days. You can assist with minimizing the review time by providing complete and accurate documentation to the RMS Portal in a timely manner. Incomplete requests, responses to RFIs that are not timely, etc. will delay the review time.
- Does previous support of a program by Teva guarantee future support?
No. Each request is evaluated on its individual merit. Please do not consider any request approved until you have received written documentation from the RMS Portal.
- A Teva employee told me that my grant request would be approved, but I received an electronic denial message from the Request Management System (RMS) Portal. Why did this occur?
No representative of Teva, except members of the Teva request review committee can approve a request. As a requestor, you should not acknowledge any verbal commitments from sales representatives, medical liaisons, or any other Teva employee, as they are not authorized to make such a commitment. Please do not consider any request approved until you have received written confirmation from the RMS Portal.
- Can I complete part of the registration and/or the online request and come back to it later?
Complete your profile information in one sitting (it is a brief form). Once that is complete you can start the registration process and you can partially complete your registration and come back later by choosing ‘save draft’. During the request submission process, you may save your data and submit your request at a later date. If you are unable to complete your request in one sitting, you may choose "save draft” for that section and continue later.
- How do I submit a signed and dated W-9?
There are several ways to submit a signed and dated W-9 form. If you already have a PDF version of the signed W-9 form, simply upload the file in the application where indicated. If you have a scanner, you can print the W-9 form, sign it, scan it into your system and then upload the scanned document in the application where indicated.
- What is a "Request for Additional Information" (RFI) and how much time do I have for completion?
A "Request for Additional Information" is made when more information is needed to consider your request. The request will be sent via e-mail. Teva will follow-up on the original request via e-mail after 5 business days. If Teva has not received all necessary information within 10 business days of the follow-up request, the request may be declined. If you have additional questions concerning the RFI you have received, please contact Teva at 1-800-961-3604 or via email at TevaRequestManagement@tevapharm.com. For faster processing, please include the grant number associated with your inquiry.
- What is the maximum file size allowed per document upload? What types of documents can be uploaded?
The recommended size of a file is 10 megabytes. However, the RMS Portal will support a file size of 20 megabytes. (How to locate the file size) 1. Locate and highlight the file or files you wish to determine the size of. 2. Right-click the file and click Properties. 3. Within the file Properties you will be able to determine the size of the file or files you have highlighted. File types supported in the RMS Portal are: .doc, .docx, .pdf, .pptx, .rft, .txt, .xls, .xlsx
- What is Teva’s policy around Open Payments Reporting (aka Physician Payments Sunshine Act) / For what programs are there Open Payments reporting required?
As of January 1, 2021, The Physician Payments Sunshine Act (“Sunshine Act”) requires “applicable manufacturers” of drugs, devices, biologicals, or medical supplies covered under Medicare, Medicaid, or the Children’s Health Insurance Program (CHIP), to report annually to CMS, in an electronic format, certain payments or other transfers of value to “covered recipients” — certain teaching hospitals listed by CMS each calendar year and (1) physicians (MD, DO, DDS, DDM, DPM, OD, DC); (2) physician assistants; (3) nurse practitioners; (4) clinical nurse specialists; (5) certified registered nurse anesthetists & anesthesiologist assistants; and (6) certified nurse-midwives.
Certain payments or transfers of value are excluded from reporting under the Sunshine Act. As relevant here, the Sunshine Act excludes from reporting certain “indirect payments” or transfers of value. CMS defined an “indirect payment” as a payment or transfer of value made by a manufacturer to a physician or teaching hospital through a third party or intermediary, in which the manufacturer “requires, instructs, directs or otherwise causes” the third party to provide payment or transfer of value, in whole or in part, to a physician or teaching hospital. In other words, “indirect payments … are made to an entity or individual (that is, a third party) to be passed through to a” physician or teaching hospital. The Sunshine Act does not require manufacturers to report indirect payments where the applicable manufacturer is “unaware” of the identity of the covered recipient during the reporting year or by the end of the second quarter of the following year.
Under the final regulations, a manufacturer is unaware of the identity of a covered recipient if the manufacturer does not “know” the identity of the covered recipient. The definition of “know” provides that a person has actual knowledge of the information, acts in deliberate ignorance of the information, or acts in reckless disregard of the truth or falsity of the information.
For non-accredited programs, grant recipients must report all payments made to physicians (MD, DO, DDS, DDM, DPM, OD, DC); physician assistants; nurse practitioners; clinical nurse specialists; certified registered nurse anesthetists & anesthesiologist assistants; and certified nurse-midwives, including honoraria and expenses related to travel, lodging, meals, and tuition subsidies for attendees. This includes faculty and attendees.
For each payment or transfer of value subject to disclosure, Teva must report the following information:
- Identifying information including: name and business address
- Specialty, NPI number, and State License Number
- Amount, date, and form of payment (e.g., cash, in-kind, etc.)
- Nature (e.g., consulting fee, food, etc.) of the payment or other transfer of value
Instructions for reporting to Teva: please use the following template to provide us the requested information within the required timeframe:
Please send the completed worksheet to the email address listed in the worksheet. Please copy the Medical Education team on the email at email@example.com.
- What information do I need to provide for chair/faculty honoraria in the Roles and Responsibilities document?
Teva reviews all honoraria payments to ensure the payments are within Teva’s Fair Market Value (FMV) guidelines. Follow the calculation in the RMS Portal - enter the hourly rate and the number of hours (this includes preparation time and presentation time). Please provide specific detail on the duties for which the chair and faculty are being paid as well as their credentials in order to justify the honoraria payments. You are encouraged to upload a document listing out the various faculty roles and responsibilities by bullet point. Next to each bullet point please list the estimated number of hours associated with each listed role and responsibility. The estimated listed number of hours should total the number of hours allocated in the RMS Portal budget application, "number of hours", column.
The following is a recommended example to assist with submitting the Roles & Responsibilities document:
- What is the Teva policy on using Teva logos on my activity materials?
Teva follows the Accreditation Council’s (ACCME) rule which states that corporate/commercial logos are not appropriate to include in educational materials or disclosure of commercial support in accredited, non-accredited and patient education programs. For more information, please refer to www.ACCME.org.
Teva suggests the following language be utilized in lieu of a logo for both a medical or patient education grant:
“This activity has been supported through an independent educational grant from Teva Pharmaceuticals.”
- What is a reconciliation?
At the conclusion of the funded activity for Independent Medical Educational Requests, recipients are required to submit a financial reconciliation detailing audience participation, use of funds, and other information to verify the supported request was used as intended. You will receive an email notification from the RMS Portal according to the end date of your activity. If you do not submit activity a financial reconciliation within 60 calendar days of completion of your activity, you may be prevented from submitting additional requests into the RMS Portal until the reconciliation is properly submitted. Please contact Teva at 1-800-961-3604 or via email at TevaRequestManagement@tevapharm.com if additional time is needed for reconciliation. For faster processing, please include the grant number associated with your inquiry.
- What if my program dates or program scope have changed for my approved request
Please contact Teva at 1-800-961-3604 or via email at TevaRequestManagement@tevapharm.com as soon you are aware of any request changes. Depending on the changes made to the program scope, the program may need to go back through the review process.
- Where can I return unused funds?
Unused Independent Medical Education and Patient Education funds along with a refund explanation letter and request ID number should be sent to: Teva Pharmaceuticals, Attention: Medical Education Department, 400 Interpace Parkway, #3, Parsippany, NJ 07054. Checks should be made payable to Teva Pharmaceuticals.
- I began a request submission at an earlier date and now the RMS Portal will not allow me to complete the request and submit for review. Why am I not able to submit the request?
Please check the homepage on www.TevaRequests.com for our portal closure and budget availability information. If you are unable to submit a previously started request, our portal is not currently open to accept new requests. You may submit your request once the RMS portal reopens.